Table 2. Concentration of eicosanoids in serum and follicular fluid (FF) of infertile women with endometriosis and infertile controls.
Eicosanoid Sample Control Endometriosis Endometriosis without OMA Endometriosis
with OMA
5-HETE Serum 82.11 (±61.75) 87.67 (±83.04) 120.45 (±88.20)a 38.47 (±30.56)a
FF 60.61 (±65.10) 91.60 (±236.86) 45.19 (±90.84) 134.05 (±325.10)
11-HETE Serum 101.74 (±74.33) 88.76 (±74.94) 89.85 (±47.47) 93.91 (±97.90)
FF 114.59 (±80.38) 136.99 (±111.2) 156.10 (±133.43) 92.36 (±53.69)
15-oxo-ETE Serum 68.67 (±67.46) 34.27 (±60.29) 45.33 (±73.93) 44.01 (±67.47)
FF 23.34 (±33.66) 11.16 (±18.66) 7.6 (±12.09) 21.81 (±30.69)
EPA Serum 8197.14 (±7959.79) 8629.82 (±5555.29) 8149.58 (±3948.42) 10294.82 (±7798.17)
FF 1159,83 (±1432.62)bc 4038,52 (±45637.61)b 2618,23 (±4802.12) 5811,50 (±5908,08)c
15-HETE Serum 82.71 (±76.00) 112.47 (±112.91) 124.54 (±102.57) 102.10 (±123.27)
FF 97.43 (±105.95) 150.83 (±200.82) 91.84 (±77.70) 205.88 (±270.60)
PGE-2 FF 18.19 (±64.42) 2.91 (±1.31) 75.59 (±127.29) 0.0 (±0.0)

Note: Data presented as mean and standard deviation. Concentration in picograms per milliliter (pg/mL). Endometriosis versus control groups comparisons: Student’s t-test. Endometriosis without OMA versus Endometriosis with OMA versus control groups: Variance test (ANOVA) and Tukey’s post hoc test. Same letters mean significant difference. Significance level: 5%.